Author:
Alsaif Nawaf A.,Dahab Mohammed A.,Alanazi Mohammed M.,Obaidullah Ahmad J.,Al-Mehizia Abdulrahman A.,Alanazi Manal M.,Aldawas Saleh,Mahdy Hazem A.,Elkady Hazem
Funder
King Saud University Deanship of Scientific Research
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference102 articles.
1. Novel thalidomide analogs: anti-angiogenic and apoptotic effects on Hep-G2 and MCF-7 cancer cell lines;Talaat;Biomed. Aging Pathol.,2014
2. Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase;Yuan;Eur. J. Med. Chem.,2019
3. Protein tyrosine kinase inhibitors: new treatment modalities?;Fabbro;Curr. Opin. Pharmacol.,2002
4. Design, synthesis, activity and docking study of sorafenib analogs bearing sulfonylurea unit;Wu;Molecules,2015
5. Tumor angiogenesis: causes, consequences, challenges and opportunities;Lugano;Cell. Mol. Life Sci.,2020
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Role of heterocycles in inhibition of VEGFR-2 – a recent update (2019–2022);RSC Medicinal Chemistry;2024
2. Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors: In vitro and in silico studies;Heliyon;2024-01
3. New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies;Computational Biology and Chemistry;2023-12
4. Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression;Pathology - Research and Practice;2023-10
5. A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies;ChemistryOpen;2023-10